Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

BACKGROUND: We demonstrated therapeutic nonequivalence of “bioequivalent” generics for meropenem, but there is no data with generics of other carbapenems. METHODS: One generic product of imipenem-cilastatin was compared with the innovator in terms of in vitro susceptibility testing, pharmaceutical e...

Descripción completa

Detalles Bibliográficos
Autores principales: Agudelo, Maria, Rodriguez, Carlos A., Zuluaga, Andres F., Vesga, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364906/
https://www.ncbi.nlm.nih.gov/pubmed/30726248
http://dx.doi.org/10.1371/journal.pone.0211096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364906/
https://www.ncbi.nlm.nih.gov/pubmed/30726248
http://dx.doi.org/10.1371/journal.pone.0211096

Ejemplares similares